Innovation and the pharmaceutical industry critical reflections on the virtues of profit /
Innovation and the pharmaceutical industry critical reflections on the virtues of profit / [electronic resource] :
edited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett.
- Salem, MA : M & M Scrivener Press, c2008.
- viii, 245 p.
- Trends and conflicts .
- Conflicts and trends. .
Includes bibliographical references and index.
Pharmaceutical innovation and the market: the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett -- The unavoidable goodness of profit: the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr -- Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi -- Pharmaceutical companies: psychopaths or scapegoats / Pepe Lee Chang -- Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor -- Pharmaceutical advertising and patient autonomy / Andrew I. Cohen -- Does America have a second drug problem? / Richard A. Epstein -- Global drug innovation in a world of financial finitude: retailing virtue to promote -- Capital formation and profit / Michael A. Rie -- Time, money, and the market for drugs / John C. Goodman -- Perils of parallel trade: reimporting prescription drugs from Canada to the U.S. / John R. Graham -- Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis.
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
Pharmaceutical industry.
Drug development.
Medical innovations.
Medical policy--United States.
Drugs--economics--United States.
Electronic books.
HD9665.5 / .I55 2008
338.4/791510973
Includes bibliographical references and index.
Pharmaceutical innovation and the market: the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett -- The unavoidable goodness of profit: the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr -- Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi -- Pharmaceutical companies: psychopaths or scapegoats / Pepe Lee Chang -- Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor -- Pharmaceutical advertising and patient autonomy / Andrew I. Cohen -- Does America have a second drug problem? / Richard A. Epstein -- Global drug innovation in a world of financial finitude: retailing virtue to promote -- Capital formation and profit / Michael A. Rie -- Time, money, and the market for drugs / John C. Goodman -- Perils of parallel trade: reimporting prescription drugs from Canada to the U.S. / John R. Graham -- Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis.
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
Pharmaceutical industry.
Drug development.
Medical innovations.
Medical policy--United States.
Drugs--economics--United States.
Electronic books.
HD9665.5 / .I55 2008
338.4/791510973